USPTO serial 79076475
QI LU
Reviewed by CopyMark Law Group
Reg. 3946913Status 706Registered
- Filing date
- Status date
- Registration date
- Apr 19, 2011
- Examiner
- BORSUK, ESTHER
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with QI LU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dana Stewart-Mekdara
Dana Stewart-Mekdara Global Trademarks, Inc.505 S. Villa Real Drive, Suite 102Anaheim Hills, CA 92807UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations, namely, injections, capsules and tablets for use in ophthalmology, oncology, and chemotherapy; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; pharmaceutical preparations, namely, injections, capsules and tablets for the treatment of inflammation; ] biomedical medicines for use in ophthalmology, oncology and chemotherapy; [ biomedical medicines for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; biomedical medicines for the treatment of diseases and disorders in the gastrointestinal system, endocrine system and psychiatric system; biomedical medicines for the treatment of inflammation; ] medicines for humans for use in ophthalmology, oncology and chemotherapy; [ medicines for humans for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; medicines for humans for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; medicines for humans for the treatment of inflammation; ] drugs for medical purposes for use in ophthalmology, oncology and chemotherapy [ ; drugs for medical purposes for the treatment of disorders of the nervous system, cardio-vascular system and respiratory system; drugs for medical purposes for the treatment of gastrointestinal system, endocrine system and psychiatric system related diseases and disorders; drugs for medical purposes, namely, the treatment of inflammation ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD
- Other trademarks owned by QILU PHARMACEUTICAL CO., LTD
- Other trademarks in Class 005
- Similar marks named QI LU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2022 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 26, 2022 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 26, 2022 | INPC | INVALIDATION PROCESSED | — |
| Aug 30, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 30, 2021 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 30, 2021 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Nov 4, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 1, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 10, 2020 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Oct 16, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Aug 28, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 19, 2020 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 12, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 25, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 25, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Mar 24, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2016 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 11, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 24, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 9, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 9, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 19, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 19, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 1, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 1, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 29, 2010 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 16, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 26, 2010 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Apr 15, 2010 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 9, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 11, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 11, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |